The Allegany County Health Department Behavioral Health Services has been made aware of increased use of Xylazine across the state. Xylazine has been involved in fatal overdoses in Allegany County.
Xylazine Fact Sheet for Public Guidance
Since 2019, Maryland has seen an increase in the use of Xylazine as an adulterant to the illegal drug
supply. Comparing the first three quarters for calendar years 2019 and 2020, the Office of the Chief
Medical Examiner (OCME) Unintentional Intoxication Death data through February 28, 2021, shows an
increase of 175% (76 to 209) in the number of opioid related overdose deaths involving Xylazine.
Xylazine is FDA approved for veterinary use as a sedative for large animals, such as horses. Xylazine is not
FDA approved for human use due to side effects, including sedation, hypotension, and bradycardia.
Xylazine is commonly used as an adulterant with heroin and fentanyl and increases the risk of overdose
What Is Xylazine?
Important Notes about Xylazine
SPONSORED BY THE ALLEGANY COUNTY HEALTH DEPARTMENT,
BEHAVIORAL HEALTH SERVICES
12501-12503 Willowbrook Road, PO Box 1745
Cumberland, Maryland 21501-1745
OUR MISSION: Prescribe Change Allegany County’s mission is to create awareness and educate the citizens of Allegany County,
Maryland about the growing crisis of opioid prescription drugs, and heroin misuse and abuse in our community.